Skip to content

Treatment of Orthostatic Hypotension in SCI

Treatment of Orthostatic Hypotension in Individuals With Spinal Cord Injury

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05839652
Acronym
SCI
Enrollment
25
Registered
2023-05-03
Start date
2023-07-01
Completion date
2026-06-30
Last updated
2024-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension

Brief summary

The purpose of this study is to identify the effects of non-pharmacological and pharmacological anti-hypotensive treatment interventions on orthostatic hemodynamic responses, symptoms of autonomic dysreflexia and orthostatic hypotension, and levels of fatigue and comfort in hypotensive individuals with SCI.

Interventions

Determine best drug and dose to increase and stabilize SBP during orthostatic tilt

Sponsors

Kessler Foundation
CollaboratorOTHER
James J. Peters Veterans Affairs Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* traumatic spinal cord injury * at least 12 months post injury * injury level of C1-T6 * AIS A, B or C * non-ambulatory * non-ventilator

Exclusion criteria

* Active psychiatric disorder * Stroke or cerebrovascular disease * Alzheimer's Disease or dementia * Unmanaged cardiac arrhythmias * Concurrent systemic, hepatic, or renal disease * Suspected or diagnosed malignancy * Neurological disease other than SCI * Self-reported history of three or more symptomatic episodes of AD per day

Design outcomes

Primary

MeasureTime frameDescription
Systolic blood pressure3 yearsdetermine differences in systolic blood pressure after midodrine, droxidopa, compression stockings and placebo

Secondary

MeasureTime frameDescription
Cerebral blood flow velocity3 yearsdetermine differences in cerebral blood flow velocity after midodrine, droxidopa, compression stockings and placebo
Symptoms of autonomic dysreflexia and orthostatic hypotension3 yearsdetermine differences in symptoms after midodrine, droxidopa, compression stockings and placebo

Countries

United States

Contacts

Primary ContactMatt G. Maher, MS
matt.maher@va.gov9733243588

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026